SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tony who wrote (21485)5/28/1998 11:06:00 AM
From: Hippieslayer  Read Replies (2) | Respond to of 32384
 
Just another blank shot from the small guns at lgnd. I'm not so sure that an approval will do much either since the drug targets an extremely small patient population. Unless something stellar comes out in regards to clinical results, looks like the next question will be if the stock will react to lgnd making money. But that's a long time from now.

With all the news, LGND has no cheerleaders on WAll St.

Dead money, IMHO.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News